Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ERT reported to protect against AD

June 20, 1997

5-HT2C/2A receptor antagonists from Egis

June 20, 1997

Eletriptan: a safe, effective and rapid antimigraine therapy

June 19, 1997

Preclinical and clinical studies indicate safety and efficacy of SB-209509/VML-251 for migraine

June 19, 1997

Preclinical studies reported for rizatriptan

June 19, 1997

Almotriptan: a novel antimigraine agent from Almirall

June 19, 1997

Preclinical profile of novel migraine abortive from BMS

June 19, 1997

Targets for antimigraine therapy: antiepileptic drugs in the treatment of migraine

June 19, 1997

Novel CCK-B antagonist with anxiolytic activity from Rotta

June 18, 1997

High-dose riboflavin for migraine prophylaxis

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...